Lyme disease is the most common vector-borne disease in the United States, with approximately 476,000 people diagnosed and treated each year.  Many patients with undiagnosed and untreated early Lyme disease will progress to disseminated Lyme disease.  Disseminated Lyme disease is often treated in the acute care setting and may be difficult for providers to identify without the classic erythema migrans rash of early localized Lyme disease. This webinar will review presentations of disseminated Lyme disease in pediatric patients as well as appropriate diagnostics and treatment plans utilizing the 2020 Lyme disease guidelines. 

Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org.
Copyright © 2023 by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. all rights reserved. 

This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an agency providing continuing education credit. individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1.0 NAPNAP contact hours of which 0.5 is pharmacology content.

NAPNAP was awarded funding to support this education via CDC’s Mobilizing Pediatric Provider Networks: An Education and Training Initiative to Prevent and Control Infectious Disease Threats federal project.